Kestra Medical Technologies, Ltd. (KMTS) vs Intellia Therapeutics, Inc. (NTLA)
A side-by-side comparison of Kestra Medical Technologies, Ltd. and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KMTS
Kestra Medical Technologies, Ltd.
$27.47HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
NTLA
Intellia Therapeutics, Inc.
$12.15HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — KMTS vs NTLA
growth of $100 · dividends reinvested · last 2yKMTS +29.8% (+13.9%/yr)NTLA +28.8% (+13.5%/yr)KMTS compounded faster over this window
KMTS NTLA
KMTS vs NTLA: by the numbers
- •NTLA is the larger company ($1.70B vs $1.61B market cap).
- •Both run net losses; KMTS's is the smaller (-140.43% vs -672.16% net margin).
Metrics side by side
Valuation
| Metric | KMTS | NTLA |
|---|---|---|
| P/S ratio | 15.08 | 28.52 |
| P/B ratio | 7.24 | 2.33 |
Profitability
| Metric | KMTS | NTLA |
|---|---|---|
| Gross margin | 53.89% | 76.47% |
| Operating margin | -134.48% | -651.67% |
| Net margin | -140.43% | -672.16% |
| ROE | -67.40% | -54.96% |
| ROIC | -47.99% | -54.45% |
Growth (annualized)
| Metric | KMTS | NTLA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.31% |
| Total return CAGR (5Y) | N/A | -37.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.